PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Hydroxy Acids”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,153 records · Page 64Linked to original sources
PubMed1992

Prostaglandins, leukotrienes, and hydroxy fatty acids in epidermis.

The skin is an organ that displays a highly active metabolism of polyunsaturated fatty acids (PUFA). Deficiency of the 18 carbon (n-6) dietary PUFA (linoleic acid) in epidermis results in scaly dermatoses and disruption of the skin barrier system. The skin possesses the enzyme systems to metabolize and interconvert a variety of lipids. For instance, it metabolizes arachidonic acid (an n-6 PUFA) via the cyclooxygenase pathway into cyclic products, predominantly prostaglandin E2 and prostaglandin F2 alpha. These prostaglandins modulate normal physiological processes at low physiological concentrations. However, at high concentrations, such as result from UV irradiation, they elicit inflammatory reactions. The skin can also metabolize 18-carbon and 20-carbon PUFA (n-6) via the 12- and 15-lipoxygenase pathways to produce predominantly monohydroxy fatty acids: 13-hydroxyoctadecadienoic acid (13-HODE), 12-hydroxyeicosatetraenoic acid (12-HETE), 15-hydroxyeicosatetraenoic acid (15-HETrE), and 15-hydroxyeicosatetraenoic acid (15-HETE). The latter two have potent anti-inflammatory properties. Therefore, it seems possible that elevation of these HETEs in vivo via dietary or topical means could suppress the cutaneous inflammatory reactions elicited by excessive generation of prostaglandins and leukotrienes. Thus, the supplementation of diets with appropriate purified vegetable oil and/or fish oil may serve as a less toxic monotherapy or as an adjunct to standard regimens in the management of skin inflammatory disorders.

Animals↗
PubMed1985

Nonsteroidal antiinflammatory agents. Part 16: Stereomeric 3-aryl-biphenylyl-hydroxy-propionic acids.

As part of a wider research project on structure-activity relationships of chiral arylalkanoic acids, stereomeric aryl- biphenylyl-hydroxypropionic acids 3a-d have been prepared and their antiinflammatory activity evaluated. Diastereomeric racemic erythro- and threo-acids have been synthesized by reaction of alpha-lithiated biphenylyl-acetic acid salts with the appropriate aldehyde. They were separated, and after attribution of their relative configuration by 1H-NMR analysis, resolved. The antiinflammatory activities of the enantiomeric potassium salts were determined by the carrageenan test.

Animals↗